Literature DB >> 3510595

Sodium and hypertension. A review.

M C Houston.   

Abstract

Abnormal sodium metabolism may be critical in the causation of certain forms of hypertension, particularly salt-sensitive hypertension. Long-term restriction of sodium intake in patients at high risk for the development of hypertension may reduce the chances of established hypertension occurring later. These high-risk patients in whom subsequent hypertension may be prevented include normotensive patients with family histories of hypertension, elderly patients, black patients, and those with low-renin hypertension. Treatment of hypertension with moderate sodium restriction to 70 mEq/day will significantly reduce blood pressure in a large percentage of patients, particularly known salt-sensitive hypertensive patients. This degree of restriction is also an effective adjunctive therapy for patients receiving antihypertensive medications. There is convincing experimental, epidemiologic, and clinical evidence that moderate sodium restriction helps prevent and assists in the treatment of hypertension in those patients who are genetically predisposed to develop primary hypertension or who already have hypertension. There is no evidence that this degree of sodium restriction is harmful.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510595

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  3 in total

Review 1.  Salt, aldosterone, and insulin resistance: impact on the cardiovascular system.

Authors:  Guido Lastra; Sonal Dhuper; Megan S Johnson; James R Sowers
Journal:  Nat Rev Cardiol       Date:  2010-08-10       Impact factor: 32.419

2.  Inhibitory action of norepinephrine on sodium transport in vascular smooth muscle cells in culture.

Authors:  M Tuck; P Hannaert; E Jeanclos; F Russo-Marie; R Garay
Journal:  Pflugers Arch       Date:  1989-03       Impact factor: 3.657

Review 3.  Current Understanding of Pressure Natriuresis.

Authors:  Eun Ji Baek; Sejoong Kim
Journal:  Electrolyte Blood Press       Date:  2021-12-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.